Literature DB >> 1733863

The iduronate sulfatase gene: isolation of a 1.2-Mb YAC contig spanning the entire gene and identification of heterogeneous deletions in patients with Hunter syndrome.

G Palmieri1, V Capra, G Romano, M D'Urso, S Johnson, D Schlessinger, P Morris, J Hopwood, P Di Natale, R Gatti, A Ballabio.   

Abstract

A recently isolated cDNA clone from the iduronate sulfatase (IDS) gene has been used both to seed a contig of overlapping yeast artificial chromosomes (YACs) and to investigate the molecular defect in patients with Hunter syndrome (MPS II). Six YAC clones were found to span the IDS gene, and those and 14 other YACs were assembled into a 1.2-Mb contig around the gene in Xq27-q28. The physical map of the region identifies several putative CpG islands, suggesting the presence of other genes in the vicinity. DNA from a patient with a translocation breakpoint in the gene also permitted the orientation of the contig in the chromosome. Southern analysis of DNA from 25 unrelated Italian Hunter syndrome patients revealed 4 with deletions or rearrangements in the IDS gene.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1733863     DOI: 10.1016/0888-7543(92)90405-h

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  10 in total

1.  Biochemical diagnosis of mucopolysaccharidoses: experience of 297 diagnoses in a 15-year period (1977-1991).

Authors:  P Di Natale; T Annella; A Daniele; T De Luca; E Morabito; R Pallini; P Rosario; G Spagnuolo
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

2.  Mucopolysaccharidosis IVA: structural gene alterations identified by Southern blot analysis and identification of racial differences.

Authors:  S Tomatsu; S Fukuda; A Cooper; J E Wraith; A Uchiyama; T Hori; Y Nakashima; N Yamada; K Sukegawa; N Kondo
Journal:  Hum Genet       Date:  1995-04       Impact factor: 4.132

3.  Molecular analysis in patients with mucopolysaccharidosis type II suggests that DXS466 maps within the Hunter gene.

Authors:  C Steglich; S Bunge; T Hulsebos; M Beck; N J Brandt; E Schwinger; J J Hopwood; A Gal
Journal:  Hum Genet       Date:  1993-09       Impact factor: 4.132

4.  Heterogeneity of DNA and RNA in Hunter patients.

Authors:  T Annella; A Daniele; P Di Natale
Journal:  Hum Genet       Date:  1993-10       Impact factor: 4.132

5.  Assessment of iduronate-2-sulfatase mRNA expression in Hunter syndrome (mucopolysaccharidosis type II).

Authors:  P L Crotty; C B Whitley
Journal:  Hum Genet       Date:  1992-11       Impact factor: 4.132

6.  Evidence for an iduronate-sulfatase pseudogene near the functional Hunter syndrome gene in Xq27.3-q28.

Authors:  M Rathmann; S Bunge; C Steglich; E Schwinger; A Gal
Journal:  Hum Genet       Date:  1995-01       Impact factor: 4.132

Review 7.  Hunter disease in the Spanish population: molecular analysis in 31 families.

Authors:  L Gort; A Chabás; M J Coll
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

8.  Mucopolysaccharidosis type II (Hunter disease): 13 gene mutations in 52 Japanese patients and carrier detection in four families.

Authors:  Y Yamada; S Tomatsu; K Sukegawa; Y Suzuki; N Kondo; J J Hopwood; T Orii
Journal:  Hum Genet       Date:  1993-09       Impact factor: 4.132

9.  Mutations in the iduronate-2-sulfatase gene in five Norwegians with Hunter syndrome.

Authors:  T C Olsen; H G Eiken; P M Knappskog; B F Kase; J E Månsson; H Boman; J Apold
Journal:  Hum Genet       Date:  1996-02       Impact factor: 4.132

10.  Molecular diagnosis of mucopolysaccharidosis type II (Hunter syndrome) by automated sequencing and computer-assisted interpretation: toward mutation mapping of the iduronate-2-sulfatase gene.

Authors:  J J Jonsson; E L Aronovich; S E Braun; C B Whitley
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.